Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorBELZEAUX, Raoul
dc.contributor.authorGRESSIER, Florence
dc.contributor.authorBOUDIEU, Ludivine
dc.contributor.authorARNOULD, Adeline
dc.contributor.authorMOREAU, Elsa
dc.contributor.authorPASTOL, Julia
dc.contributor.authorTZAVARA, Eleni
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorSUTTER-DALLAY, Anne-Laure
dc.contributor.authorSAMALIN, Ludovic
dc.date.accessioned2024-03-13T10:23:16Z
dc.date.available2024-03-13T10:23:16Z
dc.date.issued2024-02-17
dc.identifier.issn1435-1102 (Electronic) 1434-1816 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/188768
dc.description.abstractEnPURPOSE: The French Society for Biological Psychiatry and Neuropsychopharmacology and the French-speaking Marcé Society have joined forces to establish expert recommendations on the prescription of psychotropic drugs before, during, and after pregnancy in women with major depressive disorder (MDD) and bipolar disorder (BD). METHODS: To elaborate recommendations, we used the RAND/UCLA Appropriateness Method, which combines scientific evidence and expert clinicians' opinions. A written survey was completed by 48 psychiatrists, who have expertise in the management of mood disorders and/or in perinatal psychiatry. Key recommendations are provided by the scientific committee based on data analysis and interpretation of the results of the survey. RESULTS: The recommendations address the following three areas that are deemed essential in women with mood disorders, with an emphasis on screening, treatment options, and monitoring: (i) management of mood disorders in women of childbearing age, (ii) management during pregnancy, (iii) management during the post-partum period. As first-line strategies, experts recommend treating mood symptoms during pregnancy and maintaining a pharmacological treatment, even in euthymic or stabilized patients. First-line options include only medications with no teratogenic risk, and during breastfeeding, only medications without evidence of adverse effects in nursing infants. CONCLUSION: The expert consensus guidelines will help facilitate treatment decisions for clinicians in the daily assessment and management of mood disorders in women of childbearing age, during pregnancy, and in the post-partum period.
dc.language.isoENen_US
dc.subject.enBipolar disorder
dc.subject.enChildbearing age
dc.subject.enMajor depressive disorder
dc.subject.enMood disorders
dc.subject.enPost-partum pharmacotherapy
dc.subject.enPregnancy
dc.title.enFrench Society for Biological Psychiatry and Neuropsychopharmacology and French-speaking Marce Society guidelines for the management of mood disorders in women before, during, and after pregnancy
dc.title.alternativeArch Womens Ment Healthen_US
dc.typeArticle de revue
dc.identifier.doi10.1007/s00737-024-01440-6en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed38367037en_US
bordeaux.journalArchives of Women's Mental Healthen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamHEALTHY_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04502527
hal.version1
hal.date.transferred2024-03-13T10:23:17Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Archives%20of%20Women's%20Mental%20Health&rft.date=2024-02-17&rft.eissn=1435-1102%20(Electronic)%201434-1816%20(Linking)&rft.issn=1435-1102%20(Electronic)%201434-1816%20(Linking)&rft.au=BELZEAUX,%20Raoul&GRESSIER,%20Florence&BOUDIEU,%20Ludivine&ARNOULD,%20Adeline&MOREAU,%20Elsa&rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record